CASI Pharmaceuticals (CASI) Q3 2023 Earnings

14NovConfirmed
Nov 22
Q1 2023
Q2 2023
Q3 2023
-1.44
-1.08
-0.71
-0.35

Details

Expected EPS
-0.56
Actual EPS
-0.35
Surprise EPS
0.21
Surprise Percent
+37.5%

Description

CASI Pharmaceuticals (CASI) has reported earnings of -0.35 per share for Q3 2023.

0 Comments

Share your thoughts